インフルエンザワクチンの北米市場2020-2229

◆英語タイトル:NORTH AMERICA INFLUENZA VACCINE MARKET FORECAST 2020-2028
◆商品コード:INK20MY280
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年4月
◆ページ数:116
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe North America influenza vaccine market is anticipated to reach a CAGR of 6.06% over the projected period of 2020-2028. The growing number of cases of influenza is one of the significant factors augmenting market growth in the region.

MARKET INSIGHTS
The North America influenza vaccine market is further surveyed by segregating the region into the United States and Canada. In Canada, according to the experts, a type of influenza B had started circulating at the same rate as influenza A at the end of 2019, which is unusual as influenza B does not circulate until late in the season. This has caused concern among the experts as influenza B leads to a higher risk of hospitalization and deaths among children. The recent Flu Watch report published by PHAC in January 2020 explains the link between increased presence of influenza B and higher pediatric illnesses and hospitalizations. As per the PHAC, a similar number of pediatric hospitalizations due to influenza A were reported this season as compared to previous years. In Canada, the funding for childhood and adult immunization programs for influenza vaccines is different. Most of the pediatric immunization programs are publicly funded through public health programs and physician offices. Public funding for adults is limited, and patients often request for vaccines from their healthcare providers and physician offices. Moreover, certain vaccines are covered under private insurance plans or by the employer, specifically those recommended for specific risk situations such as occupation or travel, and are not publically funded.

COMPETITIVE INSIGHTS
Pfizer Inc, Abbott, Merck, Emergent Biosolutions, CSL Ltd, etc. are some of the renowned companies operating in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES `
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: VACCINE MARKET
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. GOVERNMENT IMMUNIZATION PROGRAMS TO ERADICATE AILMENTS FROM THE SOCIETY
3.3.2. RISE IN THE CASES OF INFLUENZA
3.3.3. TECHNOLOGY ADVANCEMENT
3.4. KEY RESTRAINTS
3.4.1. HIGH COST OF DEVELOPMENT
3.4.2. LENGTHY PROCESS OF DEVELOPMENT
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY TYPE
5.1. QUADRIVALENT VACCINE
5.2. TRIVALENT VACCINE
6. MARKET BY TECHNOLOGY
6.1. EGG-BASED TECHNOLOGY
6.2. CELL-BASED TECHNOLOGY
7. MARKET BY AGE GROUP
7.1. PEDIATRIC AGE GROUP
7.2. ADULT AGE GROUP
8. MARKET BY DELIVERY MODE
8.1. INJECTION
8.2. NASAL SPRAY
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
10. COMPANY PROFILES
10.1. MERCK
10.2. NOVARTIS AG
10.3. PFIZER INC
10.4. SANOFI
10.5. BIODIEM
10.6. EMERGENT BIOSOLUTIONS
10.7. F. HOFFMANN-LA ROCHE LTD
10.8. GLAXOSMITHKLINE
10.9. ABBOTT
10.10. CSL LTD



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[インフルエンザワクチンの北米市場2020-2229]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆